Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer

Molecular and Cellular Biology

Volumn 31, Issue 1, 2011, Pages 138-150

  Misquitta Ali, Christine M ^a   Cheng, Edith ^a   O'Hanlon, Dave ^a   Liu, Ni ^b   McGlade, C Jane ^a,c   Tsao, Ming Sound ^a,b   Blencowe, Benjamin J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR; SHORT HAIRPIN RNA;

ALTERNATIVE RNA SPLICING; APP GENE; ARTICLE; BREAST TUMOR; CARCINOGENESIS; CELL COMMUNICATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLON TUMOR; EXON; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MACF1 GENE; MICROARRAY ANALYSIS; NUMB GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VEGFA GENE;

ADENOCARCINOMA; ALTERNATIVE SPLICING; AMYLOID BETA-PROTEIN PRECURSOR; BASE SEQUENCE; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; EXONS; FEMALE; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; PREGNANCY; RECEPTORS, NOTCH; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78751700506     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00709-10     Document Type: Article

References (62)

1. Bani-Yaghoub, M., C. J. Kubu, R. Cowling, J. Rochira, G. N. Nikopoulos, S. Bellum, and J. M. Verdi. 2007. A switch in numb isoforms is a critical step in cortical development. Dev. Dyn. 236:696-705.
2. Bernier, G., M. Pool, M. Kilcup, J. Alfoldi, Y. De Repentigny, and R. Kothary. 2000. Acf7 (MACF) is an actin and microtubule linker protein whose expression predominates in neural, muscle, and lung development. Dev. Dyn. 219:216-225.
3. Blencowe, B. J. 2006. Alternative splicing: new insights from global analyses. Cell 126:37-47.
4. Blencowe, B. J., S. Ahmad, and L. J. Lee. 2009. Current-generation high-throughput sequencing: deepening insights into mammalian transcriptomes. Genes Dev. 23:1379-1386.
5. Blencowe, B. J., R. Issner, J. A. Nickerson, and P. A. Sharp. 1998. A coactivator of pre-mRNA splicing. Genes Dev. 12:996-1009.
6. Bric, A., C. Miething, C. U. Bialucha, C. Scuoppo, L. Zender, A. Krasnitz, Z. Xuan, J. Zuber, M. Wigler, J. Hicks, R. W. McCombie, M. T. Hemann, G. J. Hannon, S. Powers, and S. W. Lowe. 2009. Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. Cancer Cell 16:324-335.
7. Caceres, J. F., and A. R. Kornblihtt. 2002. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet. 18:186-193.
8. Calarco, J. A., S. Superina, D. O'Hanlon, M. Gabut, B. Raj, Q. Pan, U. Skalska, L. Clarke, D. Gelinas, D. van der Kooy, M. Zhen, B. Ciruna, and B. J. Blencowe. 2009. Regulation of vertebrate nervous system alternative splicing and development by an SR-related protein. Cell 138:898-910.
9. Calarco, J. A., Y. Xing, M. Cáceres, J. P. Calarco, X. Xiao, Q. Pan, C. Lee, T. M. Preuss, and B. J. Blencowe. 2007. Global analysis of alternative splicing differences between humans and chimpanzees. Genes Dev. 21:2963-2975.
10. Castle, J., P. Garrett-Engele, C. D. Armour, S. J. Duenwald, P. M. Loerch, M. R. Meyer, E. E. Schadt, R. Stoughton, M. L. Parrish, D. D. Shoemaker, and J. M. Johnson. 2003. Optimization of oligonucleotide arrays and RNA amplification protocols for analysis of transcript structure and alternative splicing. Genome Biol. 4:R66.
11. Chen, H.-J., C.-M. Lin, C.-S. Lin, R. Perez-Olle, C. L. Leung, and R. K. H. Liem. 2006. The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. Genes Dev. 20:1933-1945.
12. Chen, Y., and B. L. Tang. 2006. The amyloid precursor protein and postnatal neurogenesis/neurogeneration. Biochem. Biophys. Res. Commun. 341:1-5.
13. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
14. Clower, C. V., D. Chatterjee, Z. Wang, L. C. Cantley, M. G. Vander Heiden, and A. R. Krainer. 2010. The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc. Natl. Acad. Sci. U. S. A. 107:1894-1899.
15. Cooper, T. A., L. Wan, and G. Dreyfuss. 2009. RNA and disease. Cell 136:777-793.
16. Crews, L., E. Rockenstein, and E. Masliah. 2010. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis. Brain Struct. Funct. 214:111-126.
17. David, C. J., M. Chen, M. Assanah, P. Canoll, and J. L. Manley. 2010. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463:364-368.
18. Dho, S. E., M. B. French, S. A. Woods, and C. J. McGlade. 1999. Characterization of four mammalian numb protein isoforms. Identification of cytoplasmic and membrane-associated variants of the phosphotyrosine binding domain. J. Biol. Chem. 274:33097-33104.
19. Dooley, C. M., J. James, C. J. McGlade, and I. Ahmad. 2003. Involvement of numb in vertebrate retinal development: evidence for multiple roles of numb in neural differentiation and maturation. J. Neurobiol. 54:313-325.
20. Gitay-Goren, H., S. Soker, I. Vlodavsky, and G. Neufeld. 1992. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267:6093-6098.
21. Glatz, D. C., D. Rujescu, Y. Tang, F. J. Berendt, A. M. Hartmann, F. Faltraco, C. Rosenberg, C. Hulette, K. Jellinger, H. Hampel, P. Riederer, H. J. Moller, A. Andreadis, K. Henkel, and S. Stamm. 2006. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. J. Neurochem. 96:635-644.
22. Gulino, A., L. Di Marcotullio, and I. Screpanti. 2010. The multiple functions of Numb. Exp. Cell Res. 316:900-906.
23. Hansel, D. E., A. Rahman, S. Wehner, V. Herzog, C. J. Yeo, and A. Maitra. 2003. Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation. Cancer Res. 63:7032-7037.
24. Ho, L., K. Fukuchi, and S. G. Younkin. 1996. The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells. J. Biol. Chem. 271:30929-30934.
25. Katoh, M. 2007. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev. 3:30-38. (Pubitemid 47472809)
26. Keedy, V. L., and A. B. Sandler. 2007. Inhibition of angiogenesis in the treatment of non-small cell lung cancer. Cancer Sci. 98:1825-1830.
27. Klinck, R., A. Bramard, L. Inkel, G. Dufresne-Martin, J. Gervais-Bird, R. Madden, E. R. Paquet, C. Koh, J. P. Venables, P. Prinos, M. Jilaveanu-Pelmus, R. Wellinger, C. Rancourt, B. Chabot, and S. Abou Elela. 2008. Multiple alternative splicing markers for ovarian cancer. Cancer Res. 68:657-663.
28. Ko, S. Y., S. C. Lin, K. W. Chang, Y. K. Wong, C. J. Liu, C. W. Chi, and T. Y. Liu. 2004. Increased expression of amyloid precursor protein in oral squamous cell carcinoma. Int. J. Cancer 111:727-732.
29. Krause, K., S. Karger, S. Y. Sheu, T. Aigner, R. Kursawe, O. Gimm, K. W. Schmid, H. Dralle, and D. Fuhrer. 2008. Evidence for a role of the amyloid precursor protein in thyroid carcinogenesis. J. Endocrinol. 198:291-299.
30. Krilleke, D., Y. S. Ng, and D. T. Shima. 2009. The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure-function study. Biochem. Soc. Trans. 37:1201-1206.
31. Le, K., K. Mitsouras, M. Roy, Q. Wang, Q. Xu, S. F. Nelson, and C. Lee. 2004. Detecting tissue-specific regulation of alternative splicing as a qualitative change in microarray data. Nucleic Acids Res. 32:e180.
32. Lin, C., H. J. Chen, C. L. Leung, D. A. Parry, and R. K. Liem. 2005. Microtubule actin crosslinking factor 1b: a novel plakin that localizes to the Golgi complex. J. Cell Sci. 118:3727-3738.
33. Naor, D., S. Nedvetzki, I. Golan, L. Melnik, and Y. Faitelson. 2002. CD44 in cancer. Crit. Rev. Clin. Lab. Sci. 39:527-579.
34. Pan, Q., A. L. Saltzman, Y. K. Kim, C. Misquitta, O. Shai, L. E. Maquat, B. J. Frey, and B. J. Blencowe. 2006. Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression. Genes Dev. 20:153-158.
35. Pan, Q., O. Shai, L. J. Lee, B. J. Frey, and B. J. Blencowe. 2008. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40:1413-1415.
36. Pan, Q., O. Shai, C. Misquitta, W. Zhang, A. L. Saltzman, N. Mohammad, T. Babak, H. Siu, T. R. Hughes, Q. D. Morris, B. J. Frey, and B. J. Blencowe. 2004. Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform. Mol. Cell 16:929-941.
37. Paris, D., A. Quadros, N. Patel, A. DelleDonne, J. Humphrey, and M. Mullan. 2005. Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors. Eur. J. Pharmacol. 514:1-15.
38. Pece, S., M. Serresi, E. Santolini, M. Capra, E. Hulleman, V. Galimberti, S. Zurrida, P. Maisonneuve, G. Viale, and P. P. Di Fiore. 2004. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J. Cell Biol. 167:215-221.
39. Pio, R., and L. M. Montuenga. 2009. Alternative splicing in lung cancer. J. Thorac. Oncol. 4:674-678.
40. Roncarati, R., N. Sestan, M. H. Scheinfeld, B. E. Berechid, P. A. Lopez, O. Meucci, J. C. McGlade, P. Rakic, and L. D'Adamio. 2002. The gammasecretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling. Proc. Natl. Acad. Sci. U. S. A. 99:7102-7107.
41. Saadeddin, A., R. Babaei-Jadidi, B. Spencer-Dene, and A. S. Nateri. 2009. The links between transcription, beta-catenin/JNK signaling, and carcinogenesis. Mol. Cancer Res. 7:1189-1196.
42. Sanchez-Cespedes, M. 2009. Lung cancer biology: a genetic and genomic perspective. Clin. Transl. Oncol. 11:263-269.
43. Sandberg, R., J. R. Neilson, A. Sarma, P. A. Sharp, and C. B. Burge. 2008. Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 320:1643-1647.
44. Shai, O., Q. D. Morris, B. J. Blencowe, and B. J. Frey. 2006. Inferring global levels of alternative splicing isoforms using a generative model of microarray data. Bioinformatics 22:606-613.
45. Shibata, A., M. Hattori, H. Suda, and Y. Sakaki. 1996. Identification of cis-acting elements involved in an alternative splicing of the amyloid precursor protein (APP) gene. Gene 175:203-208. (Pubitemid 26363021)
46. Stav, D., I. Bar, and J. Sandbank. 2008. Gene expression subtraction of non-cancerous lung from smokers and non-smokers with adenocarcinoma, as a predictor for smokers developing lung cancer. J. Exp. Clin. Cancer Res. 27:45-52.
47. Takayama, K.-I., S. Tsutsumi, T. Suzuki, K. Horie-Inoue, K. Ikeda, K. Kaneshiro, T. Fujimura, J. Kumagai, T. Urano, Y. Sakaki, K. Shirahige, H. Sasano, S. Takahashi, T. Kitamura, Y. Ouchi, H. Aburatani, and S. Inoue. 2009. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Cancer Res. 69:137-142.
48. Tsao, M. S., N. Liu, T. Nicklee, F. Shepherd, and J. Viallet. 1997. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma. Clin. Cancer Res. 3:1807-1814.
49. Venables, J. P. 2006. Unbalanced alternative splicing and its significance in cancer. Bioessays 28:378-386.
50. Venables, J. P., R. Klinck, A. Bramard, L. Inkel, G. Dufresne-Martin, C. Koh, J. Gervais-Bird, E. Lapointe, U. Froehlich, M. Durand, D. Gendron, J.-P. Brosseau, P. Thibault, J.-F. Lucier, K. Tremblay, P. Prinos, R. J. Wellinger, B. Chabot, C. Rancourt, and S. A. Elela. 2008. Identification of alternative splicing markers for breast cancer. Cancer Res. 68:9525-9531.
51. Venables, J. P., R. Klinck, C. Koh, J. Gervais-Bird, A. Bramard, L. Inkel, M. Durand, S. Couture, U. Froehlich, E. Lapointe, J.-F. Lucier, P. Thibault, C. Rancourt, K. Tremblay, P. Prinos, B. Chabot, and S. A. Elela. 2009. Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol. 16:670-676.
52. Verdi, J. M., A. Bashirullah, D. E. Goldhawk, C. J. Kubu, M. Jamali, S. O. Meakin, and H. D. Lipshitz. 1999. Distinct human NUMB isoforms regulate differentiation vs. proliferation in the neuronal lineage. Proc. Natl. Acad. Sci. U. S. A. 96:10472-10476.
53. Wang, E. T., R. Sandberg, S. Luo, I. Khrebtukova, L. Zhang, C. Mayr, S. F. Kingsmore, G. P. Schroth, and C. B. Burge. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476.
54. Wang, Y. 2009. Wnt/Planar cell polarity signalling: a new paradigm for cancer therapy. Mol. Cancer Ther. 8:2103-2109.
55. Wang, Z., M. Gerstein, and M. Snyder. 2009. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10:57-63.
56. Ward, A. J., and T. A. Cooper. 2010. The pathobiology of splicing. J. Pathol. 220:152-163.
57. Westhoff, B., I. N. Colaluca, G. D'Ario, M. Donzelli, D. Tosoni, S. Volorio, G. Pelosi, L. Spaggiari, G. Mazzarol, G. Viale, S. Pece, and P. P. Di Fiore. 2009. Alterations of the Notch pathway in lung cancer. Proc. Natl. Acad. Sci. U. S. A. 106:22293-22298.
58. Yoshida, T., A. Tokunaga, K. Nakao, and H. Okano. 2003. Distinct expression patterns of splicing isoforms of mNumb in the endocrine lineage of developing pancreas. Differentiation 71:486-495. (Pubitemid 37363664)
59. Yuan, A., C. J. Yu, S. H. Kuo, W. J. Chen, F. Y. Lin, K. T. Luh, P. C. Yang, and Y. C. Lee. 2001. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J. Clin. Oncol. 19:432-441.
60. Zhang, C., M. A. Frias, A. Mele, M. Ruggiu, T. Eom, C. B. Marney, H. Wang, D. D. Licatalosi, J. J. Fak, and R. B. Darnell. 2010. Intergrative modeling defines the Nova splicing-regulatory network and its combinatorial controls. Science 329:439-443.
61. Zhang, C., H. R. Li, J. B. Fan, J. Wang-Rodriguez, T. Downs, X. D. Fu, and M. Q. Zhang. 2006. Profiling alternatively spliced mRNA isoforms for prostate cancer classification. BMC Bioinformatics 7:202.
62. Zygalaki, E., E. G. Tsaroucha, L. Kaklamanis, and E. S. Lianidou. 2007. Quantitative real-time reverse transcription PCR study of the expression of vascular endothelial growth factor (VEGF) splice variants and VEGF receptors (VEGFR-1 and VEGFR-2) in non small cell lung cancer. Clin. Chem. 53:1433-1439.